Advertisement
Canada markets close in 5 hours 29 minutes
  • S&P/TSX

    21,948.75
    +63.37 (+0.29%)
     
  • S&P 500

    5,095.26
    +46.84 (+0.93%)
     
  • DOW

    38,247.30
    +161.50 (+0.42%)
     
  • CAD/USD

    0.7319
    -0.0004 (-0.05%)
     
  • CRUDE OIL

    83.89
    +0.32 (+0.38%)
     
  • Bitcoin CAD

    87,962.27
    +1,002.74 (+1.15%)
     
  • CMC Crypto 200

    1,344.95
    -51.59 (-3.70%)
     
  • GOLD FUTURES

    2,353.70
    +11.20 (+0.48%)
     
  • RUSSELL 2000

    2,003.26
    +22.14 (+1.12%)
     
  • 10-Yr Bond

    4.6570
    -0.0490 (-1.04%)
     
  • NASDAQ

    15,879.40
    +267.64 (+1.71%)
     
  • VOLATILITY

    15.24
    -0.13 (-0.85%)
     
  • FTSE

    8,137.16
    +58.30 (+0.72%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6842
    +0.0021 (+0.31%)
     

Avicanna says 2022 was transformational despite challenging cannabis market

New York --News Direct-- Avicanna Inc

Avicanna Inc CEO Aras Azadian joined Proactive's Natalie Stoberman with the company's Year in Review including milestones reached in 2022.

Azadian said 2022 was challenging for both the biopharmaceutical and cannabis industries. Despite the challenges, Azadian said it was transformational year for Avicanna as it remained focused and deliver on its business plan.

Avicanna's aim in 2022 was to commercialize and advance the intellectual property portfolio across its four business units: Active Pharmaceutical Ingredients, Cosmetics, Medical, and Pharmaceutical, which contributed to successful exports to 18 international markets.

Contact Details

Proactive USA

ADVERTISEMENT

+1 347-449-0879

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/avicanna-says-2022-was-transformational-despite-challenging-cannabis-market-686582899